Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001386698 | SCV001587036 | pathogenic | not provided | 2020-04-13 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in CDH23 are known to be pathogenic (PMID: 11138009, 21940737). This variant has been observed in individual(s) with Usher syndrome (PMID: 25468891). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Arg1219*) in the CDH23 gene. It is expected to result in an absent or disrupted protein product. |
Gene |
RCV001386698 | SCV003930000 | pathogenic | not provided | 2022-12-06 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25468891) |
Baylor Genetics | RCV003473970 | SCV004210631 | pathogenic | Pituitary adenoma 5, multiple types | 2023-08-20 | criteria provided, single submitter | clinical testing |